CClinicalTrials.gg
Status unknownNCT05025215Updated Aug 27, 2021

The Effect of Precise Aerosol Inhalation Nursing on Sputum Excretion in Elderly Patients With Lung Surgery

An interventional study of Precise Aerosol Inhalation Nursing Program and Traditional Aerosol Inhalation Nursing Method in Inhalation, sponsored by The First Affiliated Hospital of Soochow University. Status unknown at 1 site in China. Open to participants aged 65 Years to 79 Years. Per ClinicalTrials.gov, last updated 2021-08-27.

Sponsored by The First Affiliated Hospital of Soochow University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2021, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
65 Years to 79 Years
Sex
All
01

Study summary

Comparing the effects of different kinds of aerosol inhalation nursing programs on effective sputum excretion in elderly patients with lung surgery.

Read the detailed description

Based on the traditional oxygen aerosol inhalation treatment, this study will improve it. In the process, precise body position care, time control, observation and treatment, evaluation, etc. will be used to form a precise aerosol inhalation care plan. To explore the effect of this program on effective sputum excretion in elderly patients undergoing lung surgery.

02

Conditions studied

  • Inhalation
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's planned enrollment of 200 is above the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

The First Affiliated Hospital of Soochow University is the lead sponsor of 252 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ①The patient underwent thoracoscopic lung surgery; ②There was no obvious pulmonary infection before the operation; ③Good audiovisual function, no communication barriers, able to cooperate with nebulized inhalation operation; ④Patients informed consent to this study.

Exclusion criteria

Exclusion Criteria:

  • ①Patients with mental illness; ②Acute COPD; ③Serious complications or failure of important organs after operation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Group A: Precise

    The experimental group accepts improved precise aerosol inhalation nursing program,which was based on the traditional oxygen aerosol inhalation treatment, including precise body position care, time control, observation and treatment, evaluation, etc. This group is planned to enroll 100 patients.

    Behavioral: Precise Aerosol Inhalation Nursing Program

  • Experimental
    Group B:Traditional

    The control group accepts traditional aerosol inhalation nursing method. This group is planned to enroll 100 patients.

    Behavioral: Traditional Aerosol Inhalation Nursing Method

Interventions

  • BehavioralPrecise Aerosol Inhalation Nursing Program

    The precise aerosol inhalation nursing program was based on the traditional oxygen aerosol inhalation treatment, including precise body position care, time control, observation and treatment, evaluation, etc.

  • BehavioralTraditional Aerosol Inhalation Nursing Method

    The traditional aerosol inhalation nursing method is carried out according to the operation of aerosol inhalation.

06

What researchers measure

Primary outcomes

  1. Standardization of aerosol inhalation

    The investigators use a self-made inhalation implementation standard evaluation form to evaluate whether inhalation was standard in postoperative patients.

    Time frame: From the first to the third day after surgery.

Secondary outcomes

  1. Adverse events

    Discomfort during inhalation: chest tightness, dyspnea, palpitations, elevated blood pressure, etc.

    Time frame: From the first to the third day after surgery.

  2. Viscosity of sputum

    According to the viscosity, the sputum was divided into three types: ⅰ degree (thin phlegm), ⅱ degree (moderate phlegm), ⅲ degree (severe phlegm).

    Time frame: From the first to the third day after surgery.

  3. Phlegm retention

    Sputum sounds can be heard or ausculted at the bedside.

    Time frame: From the first to the third day after surgery.

  4. Patient satisfaction

    Likert 5-level scoring method was adopted to allow patients to evaluate the nursing plan. The higher the score, the more satisfied the patients were.

    Time frame: The third day after surgery.

07

Study locations

1 of 1 sites recruiting
  • The First Affiliated Hospital of Soochow University
    Suzhou, China
    Recruiting
08

References and documents

Publications

  • Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma. 2010 Apr;47(3):251-6. doi: 10.3109/02770900903580843. PubMed 20394511 ↗
  • Press VG, Kelly CA, Kim JJ, White SR, Meltzer DO, Arora VM. Virtual Teach-To-Goal Adaptive Learning of Inhaler Technique for Inpatients with Asthma or COPD. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1032-1039.e1. doi: 10.1016/j.jaip.2016.11.018. Epub 2017 Jan 5. PubMed 28065689 ↗
  • Pedersen S, Ostergaard PA. Nasal inhalation as a cause of inefficient pulmonal aerosol inhalation technique in children. Allergy. 1983 Apr;38(3):191-4. doi: 10.1111/j.1398-9995.1983.tb01605.x. PubMed 6846746 ↗
  • Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005 Oct;50(10):1360-74; discussion 1374-5. PubMed 16185371 ↗
  • Klijn SL, Hiligsmann M, Evers SMAA, Roman-Rodriguez M, van der Molen T, van Boven JFM. Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review. NPJ Prim Care Respir Med. 2017 Apr 13;27(1):24. doi: 10.1038/s41533-017-0022-1. PubMed 28408742 ↗
  • Wu M, Woodrick NM, Arora VM, Farnan JM, Press VG. Developing a Virtual Teach-To-Goal Inhaler Technique Learning Module: A Mixed Methods Approach. J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1728-1736. doi: 10.1016/j.jaip.2017.04.032. Epub 2017 Jun 7. PubMed 28600133 ↗
  • Price DB, Roman-Rodriguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Stallberg B, van der Molen T, Chrystyn H. Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1071-1081.e9. doi: 10.1016/j.jaip.2017.01.004. Epub 2017 Mar 9. PubMed 28286157 ↗
  • Press VG, Arora VM, Trela KC, Adhikari R, Zadravecz FJ, Liao C, Naureckas E, White SR, Meltzer DO, Krishnan JA. Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial. Ann Am Thorac Soc. 2016 Jun;13(6):816-24. doi: 10.1513/AnnalsATS.201509-603OC. PubMed 26998961 ↗
  • Press VG, Arora VM, Shah LM, Lewis SL, Charbeneau J, Naureckas ET, Krishnan JA. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012 Oct;27(10):1317-25. doi: 10.1007/s11606-012-2090-9. Epub 2012 May 17. PubMed 22592354 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05025215
Lead sponsor
The First Affiliated Hospital of Soochow University
Responsible party
Sponsor
First posted
Aug 27, 2021
Start date
May 8, 2021
Primary completion
May 8, 2022 (estimated)
Completion
May 8, 2022 (estimated)
Last update
Aug 27, 2021

Study contacts

Jun Zhao
Contact
zhaojia0327@126.com
86-0512-67972216
Jing Luo
principal investigator · The First Affiliated Hospital of Soochow University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion